Displaying 211–220 of 254 research results
Aug 2, 2016
Both approaches show strong, near-term potential for providing meaningful vision to people who are otherwise blind from retinal diseases such as retinitis pigmentosa and age-related macular degeneration (AMD).
Jul 21, 2016
The trial is one of the first-ever for a stem-cell-derived therapy for RP.
Jul 1, 2016
Dr. Weleber became the 10th recipient of the Foundation’s highest honor, named after FFB co-founder Lulie Gund, during the opening lunch of the VISIONS 2016 conference.
Jul 1, 2016
At VISIONS 2016, FFB’s national conference, the Foundation honored him with its Ed Gollob Board of Directors Award for breakthrough research conducted within the past year.
Jun 24, 2016
Subretinal injection is the most common form of delivery for gene therapies currently in clinical trials.
Jun 6, 2016
Researchers in Israel are developing a gene therapy for achromatopsia that may help both sheep and humans alike.
May 5, 2016
Aditya A. Guru, 16, used whole exome sequencing (WES), an innovative genetic-screening technology, to find the mutation.
May 4, 2016
In August 2015, the biotech company Alkeus launched a multi-center TEASE Phase II clinical trial for the drug ALK-001.
May 2, 2016
When the study and the reports are completed, the ProgSTAR database will be made available to researchers and companies developing therapies.
Apr 28, 2016
Five of six patients in NightStaRx’s choroideremia gene-therapy trial continue to benefit from the treatment.